Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current considerations for the treatment of severe chronic pain: the potential for tapentadol.
Pergolizzi J, Alegre C, Blake D, Alén JC, Caporali R, Casser HR, Correa-Illanes G, Fernandes P, Galilea E, Jany R, Jones A, Mejjad O, Morovic-Vergles J, Oteo-Álvaro Á, Radrigán Araya FJ, Simões ME, Uomo G. Pergolizzi J, et al. Among authors: mejjad o. Pain Pract. 2012 Apr;12(4):290-306. doi: 10.1111/j.1533-2500.2011.00487.x. Epub 2011 Jul 29. Pain Pract. 2012. PMID: 21797962 Review.
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
Lequerré T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, Kone-Paut I, Michel M, Dernis E, Khellaf M, Limal N, Job-Deslandre C, Fautrel B, Le Loët X, Sibilia J; Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie (SOFREMIP); Club Rhumatismes et Inflammation (CRI). Lequerré T, et al. Among authors: mejjad o. Ann Rheum Dis. 2008 Mar;67(3):302-8. doi: 10.1136/ard.2007.076034. Epub 2007 Oct 18. Ann Rheum Dis. 2008. PMID: 17947302 Clinical Trial.
Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra.
Lequerré T, Vittecoq O, Pouplin S, Klemmer N, Mejjad O, Daragon A, Prieur AM, Le Loët X. Lequerré T, et al. Among authors: mejjad o. Rheumatology (Oxford). 2007 Dec;46(12):1860-2. doi: 10.1093/rheumatology/kem258. Epub 2007 Oct 25. Rheumatology (Oxford). 2007. PMID: 17965046 No abstract available.
Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort.
Le Loët X, Brazier M, Mejjad O, Boumier P, Daragon A, Gayet A, Pouplin S, Tron F, Zarnitsky C, Vittecoq O, Menard JF, Fardellone P. Le Loët X, et al. Among authors: mejjad o. Arthritis Care Res (Hoboken). 2010 Dec;62(12):1739-47. doi: 10.1002/acr.20321. Arthritis Care Res (Hoboken). 2010. PMID: 20740612 Free article.
Synovium CD20 expression is a potential new predictor of bone erosion progression in very-early arthritis treated by sequential DMARDs monotherapy -- a pilot study from the VErA cohort.
Lanfant-Weybel K, Michot C, Daveau R, Milliez PY, Auquit-Auckbur I, Fardellone P, Brazier M, Mejjad O, Daragon A, Krzanowska K, Jouen F, Tron F, Le Loarer F, Le Loët X, Vittecoq O. Lanfant-Weybel K, et al. Among authors: mejjad o. Joint Bone Spine. 2012 Dec;79(6):574-80. doi: 10.1016/j.jbspin.2011.11.006. Epub 2012 Mar 27. Joint Bone Spine. 2012. PMID: 22459417
63 results